EyeCon 2026 Banner
|Articles|April 23, 2020

COVID-19: Sun Pharmaceuticals business update

Author(s)Mark Hagler

Mark Hagler, senior vice president, head of Ophthalmics, Oncology and LTC, at Sun Pharmaceuticals, shares a business update on how the company has responded and continued operations during the coronavirus pandemic.
 


Latest CME